{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T07:12:01Z","timestamp":1782198721719,"version":"3.54.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011926","name":"European Association for Haemophilia and Allied Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011926","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jtha.2023.12.018","type":"journal-article","created":{"date-parts":[[2023,12,22]],"date-time":"2023-12-22T12:08:07Z","timestamp":1703246887000},"page":"1001-1008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Knowledge and attitudes toward gene therapy of a cohort of Italian patients with hemophilia"],"prefix":"10.1016","volume":"22","author":[{"given":"Ilaria","family":"Cutica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimosa","family":"Mortarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Garagiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Pravettoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2023.12.018_bib1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0140-6736(15)01123-X","article-title":"The past and future of haemophilia: diagnosis, treatments, and its complications","volume":"388","author":"Peyvandi","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2023.12.018_bib2","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jth.15444","article-title":"Hemophilic arthropathy: current knowledge and future perspectives","volume":"19","author":"Gualtierotti","year":"2021","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.018_bib3","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/hae.13519","article-title":"Miracle of haemophilia drugs: personal views about a few main players","volume":"24","author":"Mannucci","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.12.018_bib4","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1080\/17474086.2022.2131526","article-title":"Emicizumab: a novel drug in hemophilia A prophylaxis - a narrative review","volume":"15","author":"Mazurkiewicz","year":"2022","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jtha.2023.12.018_bib5","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/ph15101183","article-title":"Updates on novel non-replacement drugs for hemophilia","volume":"15","author":"Gualtierotti","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.jtha.2023.12.018_bib6","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/hae.13816","article-title":"Clinical advances in gene therapy updates on clinical trials of gene therapy in haemophilia","volume":"25","author":"Peyvandi","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.12.018_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1182\/blood.2019003777","article-title":"Gene therapy for hemophilia: a review on clinical benefit, limitations, and remaining issues","volume":"138","author":"Leebeek","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2023.12.018_bib8","doi-asserted-by":"crossref","first-page":"3335","DOI":"10.1016\/j.ymthe.2022.09.020","article-title":"First conditional marketing authorization approval in the European Union for hemophilia \"A\" gene therapy","volume":"30","author":"VandenDriessche","year":"2022","journal-title":"Mol Ther"},{"key":"10.1016\/j.jtha.2023.12.018_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s40265-023-01845-0","article-title":"Etranacogene dezaparvovec: first approval","volume":"83","author":"Heo","year":"2023","journal-title":"Drugs"},{"key":"10.1016\/j.jtha.2023.12.018_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/hae.14190","article-title":"Patient perspectives regarding gene therapy in haemophilia: Interviews from the PAVING study","volume":"27","author":"van Overbeeke","year":"2021","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.12.018_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s40271-019-00395-6","article-title":"Patient perspectives on novel treatments in haemophilia: a qualitative study","volume":"13","author":"van Balen","year":"2020","journal-title":"Patient"},{"key":"10.1016\/j.jtha.2023.12.018_bib12","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/s13023-022-02256-2","article-title":"The experiences of people with haemophilia and their families of gene therapy in a clinical trial setting: regaining control, the Exigency study","volume":"17","author":"Fletcher","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.jtha.2023.12.018_bib13","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/hae.13673","article-title":"Members of the WFH Gene Therapy Round Table\u00a0Program Committee and Organizing Committee. The 1st WFH gene therapy round table: understanding the landscape and challenges of gene therapy for haemophilia around the world","volume":"25","author":"Pierce","year":"2019","journal-title":"Haemophilia"},{"key":"10.1016\/j.jtha.2023.12.018_bib14","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1093\/eurpub\/ckv043","article-title":"Health literacy in Europe: comparative results of the European health literacy survey (HLS-EU)","volume":"25","author":"S\u00f8rensen","year":"2015","journal-title":"Eur J Public Health"},{"key":"10.1016\/j.jtha.2023.12.018_bib15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1089\/humc.2017.253","article-title":"Practical implications of factor IX gene transfer for individuals with hemophilia B: a clinical perspective","volume":"29","author":"Miesbach","year":"2018","journal-title":"Hum Gene Ther Clin Dev"},{"key":"10.1016\/j.jtha.2023.12.018_bib16","first-page":"67","article-title":"Many factor VIII products available in the treatment of hemophilia A: an embarrassment of riches?","volume":"8","author":"Lieuw","year":"2017","journal-title":"J\u00a0Blood Med"},{"key":"10.1016\/j.jtha.2023.12.018_bib17","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/rth2.12326","article-title":"Hemophilia gene therapy knowledge and perceptions: results of an international survey","volume":"4","author":"Peyvandi","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2023.12.018_bib18","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1177\/0013164495055005017","article-title":"Decision-making style: the development and assessment of a new measure","volume":"55","author":"Scott","year":"1995","journal-title":"Educ Psychol Meas"},{"key":"10.1016\/j.jtha.2023.12.018_bib19","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.paid.2007.10.017","article-title":"A\u00a0contribution to the Italian validation of the General Decision-making Style Inventory","volume":"44","author":"Gambetti","year":"2008","journal-title":"Pers Individ Dif"},{"key":"10.1016\/j.jtha.2023.12.018_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1017\/S1930297500000334","article-title":"A\u00a0domain-specific risk-taking (DOSPERT) scale for adult populations","volume":"1","author":"Blais","year":"2006","journal-title":"Judg Decis Mak"},{"key":"10.1016\/j.jtha.2023.12.018_bib21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.3324\/haematol.2019.232132","article-title":"Hemophilia therapy: the future has begun","volume":"105","author":"Mannucci","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2023.12.018_bib22","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.pec.2012.10.019","article-title":"All Aspects of Health Literacy Scale (AAHLS): developing a tool to measure functional, communicative, and critical health literacy in primary healthcare settings","volume":"90","author":"Chinn","year":"2013","journal-title":"Patient Educ Couns"},{"key":"10.1016\/j.jtha.2023.12.018_bib23","first-page":"3","article-title":"Health literacy, health numeracy, and trust in doctor: effects on key patient health outcomes","volume":"54","author":"Netemeyer","year":"2020","journal-title":"J\u00a0Con Aff"},{"key":"10.1016\/j.jtha.2023.12.018_bib24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1509\/jppm.15.140","article-title":"Responsibility and well-being: resource integration under responsibilization in expert services","volume":"35","author":"Anderson","year":"2016","journal-title":"J\u00a0Public Policy Mark"},{"key":"10.1016\/j.jtha.2023.12.018_bib25","doi-asserted-by":"crossref","first-page":"12","DOI":"10.37897\/RJMP.2019.1.2","article-title":"Improving doctor-patient communication in a primary care setting","volume":"14","author":"Korzh","year":"2019","journal-title":"Rom J Med Pract"},{"key":"10.1016\/j.jtha.2023.12.018_bib26","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/ACM.0000000000000603","article-title":"The patient-as-partner approach in health care: a conceptual framework for a necessary transition","volume":"90","author":"Karazivan","year":"2015","journal-title":"Acad Med"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623009169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783623009169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T21:09:30Z","timestamp":1762549770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783623009169"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S1538783623009169"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2023.12.018","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge and attitudes toward gene therapy of a cohort of Italian patients with hemophilia","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2023.12.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}